Prediction of New-Onset Heart Failure in Patients With Type 2 Diabetes Derived From ALTITUDE and CANVAS
Source : https://pubmed.ncbi.nlm.nih.gov/38584567/
In patients with T2D, higher NT-proBNP level, TnT level and BMI are independent and externally validated predictors of new-onset HF, including patients using an SGLT2 inhibitor. This newly developed model...
In patients with type 2 diabetes, higher NT-proBNP level, troponin T level, and BMI are independent and externally validated predictors of new-onset HF, including patients taking sodium-glucose cotransporter 2 inhibitors.
Semaglutide in Patients With Obesity-Related Heart Failure and Type 2 Diabetes
Source : https://pubmed.ncbi.nlm.nih.gov/38587233/
Among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, semaglutide led to larger reductions in heart failure-related symptoms and physical limitations and greater weight loss...
Among patients with obesity-related HF with preserved ejection fraction and type 2 diabetes, semaglutide led to larger reductions in HF-related symptoms and physical limitations and greater weight loss than placebo at 1 year.
Experts warn that patients with obesity and type 2 diabetes do not have the luxury of waiting until 2041 for comprehensive coverage of metabolic surgery.
Associations of Regional Body Fat With Risk of Cardiovascular Disease and Mortality Among Individuals With Type 2 Diabetes
AbstractObjectives. We aimed to prospectively examine the association between regional body fat and risk of cardiovascular disease (CVD) in individuals wit
Higher arm fat percentage was linearly associated with increased CVD risk, whereas higher trunk fat percentage was nonlinearly associated with increased CVD risk.
The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications
Source : https://www.mdpi.com/1420-3049/29/6/1236
Type 2 diabetes mellitus is a multifactorial disorder whose primary manifestation usually initiates with elevated blood sugar levels. Several antidiabetic agents are used to manage type 2 diabetes mellitus, of...
Coadministration of grapefruit with empagliflozin should be cautiously monitored and avoided because grapefruit elevates the plasma level of empagliflozin.